Rs 875
Q1 FY26 performance Operating Highlights Q1 FY26 Financial Highlights Revenue from Operations Rs 875 Cr ( 11% Y-o-Y) USD 102 Mn* Operating EBITDA margin 23.6% (21.5% in Q1 FY25) Reported PAT before
11%
rformance Operating Highlights Q1 FY26 Financial Highlights Revenue from Operations Rs 875 Cr ( 11% Y-o-Y) USD 102 Mn* Operating EBITDA margin 23.6% (21.5% in Q1 FY25) Reported PAT before exceptio
23.6%
l Highlights Revenue from Operations Rs 875 Cr ( 11% Y-o-Y) USD 102 Mn* Operating EBITDA margin 23.6% (21.5% in Q1 FY25) Reported PAT before exceptional items : Rs 87 Cr (59% YoY) • • • • • Syng
21.5%
ights Revenue from Operations Rs 875 Cr ( 11% Y-o-Y) USD 102 Mn* Operating EBITDA margin 23.6% (21.5% in Q1 FY25) Reported PAT before exceptional items : Rs 87 Cr (59% YoY) • • • • • Syngene suc
Rs 87
102 Mn* Operating EBITDA margin 23.6% (21.5% in Q1 FY25) Reported PAT before exceptional items : Rs 87 Cr (59% YoY) • • • • • Syngene successfully completed a USFDA Good Clinical Practices (GCP) i
59%
perating EBITDA margin 23.6% (21.5% in Q1 FY25) Reported PAT before exceptional items : Rs 87 Cr (59% YoY) • • • • • Syngene successfully completed a USFDA Good Clinical Practices (GCP) inspecti
INR 86
e top 20 lifescience companies globally *INR converted into USD at the exchange rate of 1 USD = ~ INR 86 Putting Science to Work 5 2 Syngene – Putting Science to Work Partner in innovation: #Putting Sc
Rs. 5 Billion
olecules • Extension of collaboration with BMS; • Merger of Clinigene • Crossed annual turnover of Rs. 5 Billion Foundation • Operations started • Expansion of R&D Lab • Granted 100% EOU status by the Governme
100%
annual turnover of Rs. 5 Billion Foundation • Operations started • Expansion of R&D Lab • Granted 100% EOU status by the Government of India 1993 – 2000 2010 – 2014 2001 – 2009 Expansion • Exp
Rs. 3,642
Hyderabad and Mangalore in India and Baltimore in USA qualified to meet international standards Rs. 3,642 Cr (US$430* Mn) FY25 Revenue from operations Rs. 475 Cr** FY25 PAT 8,235 headcount including 5,6
Rs. 475
qualified to meet international standards Rs. 3,642 Cr (US$430* Mn) FY25 Revenue from operations Rs. 475 Cr** FY25 PAT 8,235 headcount including 5,641 talented scientists 92% energy from renewable sour
92%
enue from operations Rs. 475 Cr** FY25 PAT 8,235 headcount including 5,641 talented scientists 92% energy from renewable sources * All figures are as on March 31, 2025 / FY2025 **before exception